Alector Inc (STU:0Z2)
€ 3.98 -0.02 (-0.5%) Market Cap: 391.41 Mil Enterprise Value: -93.80 Mil PE Ratio: 0 PB Ratio: 2.37 GF Score: 62/100

Alector Inc at Barclays Global Healthcare Conference Transcript

Mar 16, 2022 / 07:20PM GMT
Release Date Price: €12.2 (+1.67%)
Carter Lewis Gould
Barclays Bank PLC, Research Division - Senior Analyst

Great. Well, good afternoon, and welcome to the Barclays Global Healthcare Conference. My name is Carter Gould, senior biopharma analyst here at Barclays. And as we enter the afternoon, we're very pleased to welcome Alector to the stage.

Joining us from the company is Co-Founder, CEO, Arnon Rosenthal. Arnon, thank you very much for joining us. I know it's a busy time for the company. You guys had data at AD/PD host -- had a call yesterday on that. I think the presentation was today or -- I think that's right. So I know a busy time for you. Thanks for taking the time out to speak with us today.

Arnon Rosenthal
Alector, Inc. - Co-Founder, CEO & Director

Yes. Thank you for the invitation, and thank you, everyone, for joining this (inaudible).

Carter Lewis Gould
Barclays Bank PLC, Research Division - Senior Analyst

Perfect. So maybe before we jump into Q&A, I think it would be helpful to give a little background of the company

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot